Brind.

Innoviva received royalties from GSK sales and acquired assets from Entasis Therapeutics.

1 report, 1 independent Updated Aug 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Innoviva (United States)GSKEntasis Therapeutics

Keep exploring

The entities involved

Innoviva (United States)
company in Burlingame, United States

Nothing else this week.
GSK
British multinational pharmaceutical and biotechnology company
- Clement Fourny joins Biodextris as CEO, a company that originated as a GSK development center.Mon 15:26
- GSK acquired Sierra Oncology.Mon 14:28

Related events

Collaboration revenue realization from Pfizer and GSK backing royalty financing for Spero Therapeutics.Aug 20

Coverage

Newest first; wire copies grouped

Aug 26Business WireInnoviva to Participate in Upcoming Investor Conferences BURLINGAME, Calif., August 26, 2025--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding compa